A structural keystone for drug design

3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For t...

Full description

Bibliographic Details
Main Authors: Rother Kristian, Dunkel Mathias, Michalsky Elke, Trissl Silke, Goede Andrean, Leser Ulf, Preissner Robert
Format: Article
Language:English
Published: De Gruyter 2006-06-01
Series:Journal of Integrative Bioinformatics
Online Access:http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT
id doaj-2a44beb70a98440892c966597fdfdd3a
record_format Article
spelling doaj-2a44beb70a98440892c966597fdfdd3a2020-11-25T00:27:50ZengDe GruyterJournal of Integrative Bioinformatics1613-45162006-06-0131213110.1515/jib-2006-19biecoll-jib-2006-19A structural keystone for drug designRother Kristian0Dunkel Mathias1Michalsky Elke2Trissl Silke3Goede Andrean4Leser Ulf5Preissner Robert6Institute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Computer Science, Humboldt-Universität zu Berlin, Unter den Linden 6, 10099 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, GermanyInstitute of Computer Science, Humboldt-Universität zu Berlin, Unter den Linden 6, 10099 Berlin, GermanyInstitute of Biochemistry, Charité Universitätsmedizin Berlin, Monbijoustraße 2, 10117 Berlin, Germany3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For this purpose we have built a web resource bridging protein and ligand databases. It consists of three parts: i) A data warehouse on annotation of protein structures that integrates many well-known databases such as Swiss-Prot, SCOP, ENZYME and others. ii) A conformational library of structures of approved drugs. iii) A conformational library of ligands from the PDB, linking the realms of proteins and small molecules.http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT
collection DOAJ
language English
format Article
sources DOAJ
author Rother Kristian
Dunkel Mathias
Michalsky Elke
Trissl Silke
Goede Andrean
Leser Ulf
Preissner Robert
spellingShingle Rother Kristian
Dunkel Mathias
Michalsky Elke
Trissl Silke
Goede Andrean
Leser Ulf
Preissner Robert
A structural keystone for drug design
Journal of Integrative Bioinformatics
author_facet Rother Kristian
Dunkel Mathias
Michalsky Elke
Trissl Silke
Goede Andrean
Leser Ulf
Preissner Robert
author_sort Rother Kristian
title A structural keystone for drug design
title_short A structural keystone for drug design
title_full A structural keystone for drug design
title_fullStr A structural keystone for drug design
title_full_unstemmed A structural keystone for drug design
title_sort structural keystone for drug design
publisher De Gruyter
series Journal of Integrative Bioinformatics
issn 1613-4516
publishDate 2006-06-01
description 3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For this purpose we have built a web resource bridging protein and ligand databases. It consists of three parts: i) A data warehouse on annotation of protein structures that integrates many well-known databases such as Swiss-Prot, SCOP, ENZYME and others. ii) A conformational library of structures of approved drugs. iii) A conformational library of ligands from the PDB, linking the realms of proteins and small molecules.
url http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT
work_keys_str_mv AT rotherkristian astructuralkeystonefordrugdesign
AT dunkelmathias astructuralkeystonefordrugdesign
AT michalskyelke astructuralkeystonefordrugdesign
AT trisslsilke astructuralkeystonefordrugdesign
AT goedeandrean astructuralkeystonefordrugdesign
AT leserulf astructuralkeystonefordrugdesign
AT preissnerrobert astructuralkeystonefordrugdesign
AT rotherkristian structuralkeystonefordrugdesign
AT dunkelmathias structuralkeystonefordrugdesign
AT michalskyelke structuralkeystonefordrugdesign
AT trisslsilke structuralkeystonefordrugdesign
AT goedeandrean structuralkeystonefordrugdesign
AT leserulf structuralkeystonefordrugdesign
AT preissnerrobert structuralkeystonefordrugdesign
_version_ 1725338190350385152